Retagliptin Phosphate/Metformin Hydrochloride

磷酸瑞格列汀/盐酸二甲双胍

Report date: 2026/03/30 17:02:26

Base Information

Drug NameRetagliptin Phosphate/Metformin Hydrochloride
Drug Alias NameMetformin Hydrochloride+Retagliptin Phosphate盐酸二甲双胍+磷酸瑞格列汀Metformin Hydrochloride/Retagliptin Phosphate磷酸瑞格列汀盐酸二甲双胍盐酸二甲双胍/磷酸瑞格列汀 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryMainland China
Original Approved Date2025/05/20
Country/TerritoryMainland China
CombinationsYes Retagliptin PhosphateMetformin Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Shengdi Pharmaceutical Co Ltd
Inactive CompaniesJiangsu Hengrui Medicine Co Ltd
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A